ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MILTON JOLIVETTE MEDICAL DOCTOR

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,928Medicare Part D Prescriptions Filled, Including Refills

Rank: 199 out of 680

$433K Total Retail Price of All Prescriptions

Rank: 324 out of 680

434 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

24% of this provider’s 434 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 9,356 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LOVASTATIN 422 395 1 44
HYDROCODONE-ACETAMINOPHEN 392 283 S3 2 4
AMLODIPINE BESYLATE 381 350 3 1
LISINOPRIL 366 325 4 5
METFORMIN HCL 357 309 5 8
LEVOTHYROXINE SODIUM 318 275 6 2
TRAMADOL HCL 252 221 7 18
POTASSIUM CHLORIDE 236 212 8 14
GLYBURIDE MICRONIZED 209 193 R 9 232
TRIAMTERENE-HCTZ 201 182 10 52
OMEPRAZOLE 185 173 11 7
CIPROFLOXACIN HCL 184 161 12 57
ALLOPURINOL 169 148 13 33
PRAVASTATIN SODIUM 155 116 14 10
CITALOPRAM HBR 146 116 15 22
SIMVASTATIN 145 134 16 3
METOPROLOL SUCCINATE 137 132 17 13
DONEPEZIL HCL 122 122 18 27
CRESTOR 117 95 19 25
RANITIDINE HCL 115 101 20 56
METHYLPREDNISOLONE 113 98 21 93
LISINOPRIL-HYDROCHLOROTHIAZIDE 111 103 22 37
ATENOLOL 108 102 23 19
HYDROCHLOROTHIAZIDE 108 88 23 9
BISOPROLOL-HYDROCHLOROTHIAZIDE 100 100 25 156
MELOXICAM 99 83 26 24
NEXIUM 99 92 26 16
SYNTHROID 99 74 26 38
CARVEDILOL 94 62 29 23
WARFARIN SODIUM 93 87 30 20
TRIAMTERENE-HYDROCHLOROTHIAZID 93 93 30 264
METOPROLOL TARTRATE 90 88 32 12
TRAZODONE HCL 82 76 33 48
FUROSEMIDE 79 64 34 6
SPIRONOLACTONE-HCTZ 79 73 34 259
TORSEMIDE 77 44 36 163
ENALAPRIL MALEATE 76 76 37 65
ISOSORBIDE MONONITRATE ER 75 54 38 59
GLIMEPIRIDE 74 58 39 29
AZITHROMYCIN 73 61 40 42
LOSARTAN-HYDROCHLOROTHIAZIDE 69 65 41 51
ALENDRONATE SODIUM 68 68 42 32
FAMOTIDINE 66 59 43 89
PROPRANOLOL HCL 66 54 43 145
ATORVASTATIN CALCIUM 64 48 45 11
CLONIDINE HCL 62 62 46 36
TAMSULOSIN HCL 57 57 47 34
DIOVAN 57 34 47 31
DIOVAN HCT 55 33 49 55
DOXYCYCLINE HYCLATE 55 42 49 95
HUMULIN N 55 36 49 246
CARAFATE 55 54 49 273
LANTUS 54 36 53 49
POLYETHYLENE GLYCOL 3350 54 49 53 62
GLIPIZIDE ER 52 45 55 108
VERAPAMIL ER 52 40 55 100
SPIRIVA 51 43 57 70
NAMENDA 51 51 57 35
ZOLPIDEM TARTRATE 50 30 59 17
BISOPROLOL FUMARATE 50 48 59 173
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 23, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.